127 related articles for article (PubMed ID: 29656465)
1. Structural Characterization of the Interaction of the Fibroblast Growth Factor Receptor with a Small Molecule Allosteric Inhibitor.
Kappert F; Sreeramulu S; Jonker HRA; Richter C; Rogov VV; Proschak E; Hargittay B; Saxena K; Schwalbe H
Chemistry; 2018 Jun; 24(31):7861-7865. PubMed ID: 29656465
[TBL] [Abstract][Full Text] [Related]
2. Anticancer molecules targeting fibroblast growth factor receptors.
Liang G; Liu Z; Wu J; Cai Y; Li X
Trends Pharmacol Sci; 2012 Oct; 33(10):531-41. PubMed ID: 22884522
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling.
Herbert C; Schieborr U; Saxena K; Juraszek J; De Smet F; Alcouffe C; Bianciotto M; Saladino G; Sibrac D; Kudlinzki D; Sreeramulu S; Brown A; Rigon P; Herault JP; Lassalle G; Blundell TL; Rousseau F; Gils A; Schymkowitz J; Tompa P; Herbert JM; Carmeliet P; Gervasio FL; Schwalbe H; Bono F
Cancer Cell; 2013 Apr; 23(4):489-501. PubMed ID: 23597563
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor signaling affects vascular outgrowth and is required for the maintenance of blood vessel integrity.
De Smet F; Tembuyser B; Lenard A; Claes F; Zhang J; Michielsen C; Van Schepdael A; Herbert JM; Bono F; Affolter M; Dewerchin M; Carmeliet P
Chem Biol; 2014 Oct; 21(10):1310-1317. PubMed ID: 25200605
[TBL] [Abstract][Full Text] [Related]
5. Tumor vasculature is regulated by FGF/FGFR signaling-mediated angiogenesis and bone marrow-derived cell recruitment: this mechanism is inhibited by SSR128129E, the first allosteric antagonist of FGFRs.
Fons P; Gueguen-Dorbes G; Herault JP; Geronimi F; Tuyaret J; Frédérique D; Schaeffer P; Volle-Challier C; Herbert JM; Bono F
J Cell Physiol; 2015 Jan; 230(1):43-51. PubMed ID: 24760775
[TBL] [Abstract][Full Text] [Related]
6. The fibroblast growth factor receptor antagonist SSR128129E inhibits fat accumulation via suppressing adipogenesis in mice.
Zhang X; Wen X; Hu G; Zhang Q; Sun Q; Jia Y; Liu Y; Lin H; Li H
Mol Biol Rep; 2022 Sep; 49(9):8641-8649. PubMed ID: 35731366
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evidence that SSR128129E--a novel small-molecule multi-fibroblast growth factor receptor blocker--radiosensitises human glioblastoma.
Ader I; Delmas C; Skuli N; Bonnet J; Schaeffer P; Bono F; Cohen-Jonathan-Moyal E; Toulas C
Eur J Cancer; 2014 Sep; 50(13):2351-9. PubMed ID: 24953334
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors.
Zhang Y; Liu H; Zhang Z; Wang R; Liu T; Wang C; Ma Y; Ai J; Zhao D; Shen J; Xiong B
Molecules; 2017 Apr; 22(4):. PubMed ID: 28379191
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of pyrazolylaminoquinazoline derivatives as highly potent pan-fibroblast growth factor receptor inhibitors.
Fan J; Dai Y; Shao J; Peng X; Wang C; Cao S; Zhao B; Ai J; Geng M; Duan W
Bioorg Med Chem Lett; 2016 Jun; 26(11):2594-9. PubMed ID: 27117427
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
Bono F; De Smet F; Herbert C; De Bock K; Georgiadou M; Fons P; Tjwa M; Alcouffe C; Ny A; Bianciotto M; Jonckx B; Murakami M; Lanahan AA; Michielsen C; Sibrac D; Dol-Gleizes F; Mazzone M; Zacchigna S; Herault JP; Fischer C; Rigon P; Ruiz de Almodovar C; Claes F; Blanc I; Poesen K; Zhang J; Segura I; Gueguen G; Bordes MF; Lambrechts D; Broussy R; van de Wouwer M; Michaux C; Shimada T; Jean I; Blacher S; Noel A; Motte P; Rom E; Rakic JM; Katsuma S; Schaeffer P; Yayon A; Van Schepdael A; Schwalbe H; Gervasio FL; Carmeliet G; Rozensky J; Dewerchin M; Simons M; Christopoulos A; Herbert JM; Carmeliet P
Cancer Cell; 2013 Apr; 23(4):477-88. PubMed ID: 23597562
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Discovery of a Series of 5H-Pyrrolo[2,3-b]pyrazine FGFR Kinase Inhibitors.
Jiang A; Liu Q; Wang R; Wei P; Dai Y; Wang X; Xu Y; Ma Y; Ai J; Shen J; Ding J; Xiong B
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562726
[TBL] [Abstract][Full Text] [Related]
12. [Development and ligand-protein interaction of small molecule anti-tumor FGFR inhibitors].
Li XL; Qiu R; Li J; Hai L; Wu Y
Yao Xue Xue Bao; 2016 Nov; 51(11):1689-97. PubMed ID: 29908111
[TBL] [Abstract][Full Text] [Related]
13. [SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling].
Herbert C; Alcouffe C; Bono F
Med Sci (Paris); 2013 Oct; 29(10):834-6. PubMed ID: 24148118
[No Abstract] [Full Text] [Related]
14. Thalidomide and Its Analogs Differentially Target Fibroblast Growth Factor Receptors: Thalidomide Suppresses FGFR Gene Expression while Pomalidomide Dampens FGFR2 Activity.
Sundaresan L; Kumar P; Manivannan J; Balaguru UM; Kasiviswanathan D; Veeriah V; Anishetty S; Chatterjee S
Chem Res Toxicol; 2019 Apr; 32(4):589-602. PubMed ID: 30834740
[TBL] [Abstract][Full Text] [Related]
15. Recent developments and advances of FGFR as a potential target in cancer.
Xue WJ; Li MT; Chen L; Sun LP; Li YY
Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Biological Evaluation of 6-(2,6-Dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors.
Zhang Z; Zhao D; Dai Y; Cheng M; Geng M; Shen J; Ma Y; Ai J; Xiong B
Molecules; 2016 Oct; 21(10):. PubMed ID: 27782099
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibition of fibroblast growth factor receptors in cancer.
Liang G; Chen G; Wei X; Zhao Y; Li X
Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors.
Wang Y; Li L; Fan J; Dai Y; Jiang A; Geng M; Ai J; Duan W
J Med Chem; 2018 Oct; 61(20):9085-9104. PubMed ID: 29522671
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Development of a Series of Pyrazolo[3,4-
Wang Y; Dai Y; Wu X; Li F; Liu B; Li C; Liu Q; Zhou Y; Wang B; Zhu M; Cui R; Tan X; Xiong Z; Liu J; Tan M; Xu Y; Geng M; Jiang H; Liu H; Ai J; Zheng M
J Med Chem; 2019 Aug; 62(16):7473-7488. PubMed ID: 31335138
[TBL] [Abstract][Full Text] [Related]
20. Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy.
Szlachcic A; Zakrzewska M; Lobocki M; Jakimowicz P; Otlewski J
Drug Des Devel Ther; 2016; 10():2547-60. PubMed ID: 27563235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
